1. Bone turnover markers: response to comments by Seeman and Nguyen. Issue 1 (January 2016) Authors: Naylor, K.; Jacques, R.; Paggiosi, M.; Gossiel, F.; Peel, N.; McCloskey, E.; Walsh, J.; Eastell, R. Journal: Osteoporosis international Issue: Volume 27:Issue 1(2016) Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Response of bone turnover markers to raloxifene treatment in postmenopausal women with osteopenia. Issue 8 (August 2016) Authors: Naylor, K.; Jacques, R.; Peel, N.; Gossiel, F.; Eastell, R. Journal: Osteoporosis international Issue: Volume 27:Issue 8(2016) Page Start: 2585 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study. Issue 1 (January 2016) Authors: Naylor, K.; Jacques, R.; Paggiosi, M.; Gossiel, F.; Peel, N.; McCloskey, E.; Walsh, J.; Eastell, R. Journal: Osteoporosis international Issue: Volume 27:Issue 1(2016) Page Start: 21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The cost‐effectiveness of the Dose Adjustment for Normal Eating (DAFNE) structured education programme: an update using the Sheffield Type 1 Diabetes Policy Model. Issue 10 (19th August 2013) Authors: Kruger, J.; Brennan, A.; Thokala, P.; Basarir, H.; Jacques, R.; Elliott, J.; Heller, S.; Speight, J. Journal: Diabetic medicine Issue: Volume 30:Issue 10(2013:Oct.) Page Start: 1236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗